Tenax Therapeutics (TENX) Long-Term Investments (2015 - 2020)

Tenax Therapeutics' Long-Term Investments history runs 5 years deep, the most recent figure standing at $10723.0 for Q2 2020.

• In Q2 2020, Long-Term Investments changed N/A year-over-year to $10723.0; the TTM figure through Jun 2020 stood at $10723.0 (changed N/A YoY), while the FY2017 annual figure was $1.8 million, down 78.93% from the prior year.
• Long-Term Investments came in at $10723.0 for Q2 2020 at Tenax Therapeutics, down from $296349.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $19.6 million in Q2 2016 to a low of $10723.0 in Q2 2020.
• A 4-year average of $5.5 million and a median of $2.3 million in 2017 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments tumbled 52.35% in 2016 and plunged 91.07% in 2018, its largest moves.
• Tenax Therapeutics' Long-Term Investments stood at $8.6 million in 2016, then tumbled by 78.93% to $1.8 million in 2017, then sank by 83.62% to $296349.0 in 2018, then slumped by 96.38% to $10723.0 in 2020.
• According to Business Quant data, Long-Term Investments over the past three periods registered $10723.0, $296349.0, and $297378.0 for Q2 2020, Q3 2018, and Q2 2018 respectively.

Peer Comparison